Business
DrugBank Announces Leadership Transition as Company Accelerates into AI-Driven Future
DrugBank, the premier provider of structured biomedical intelligence, today announced a strategic leadership transition designed to propel the company's next phase of AI-powered innovation and global growth. Effective October 6, Lisa Downey has been appointed Chief Executive Officer (CEO), while Mike Wilson, DrugBank's Co-Founder, will transition from CEO to Chief Product Officer (CPO), focusing on advancing DrugBank's AI and data intelligence capabilities.
About this update from Globaldata Plc
[{"type":"text","content":"EDMONTON, AB, Oct. 21, 2025 /CNW/ - DrugBank, the premier provider of structured biomedical intelligence, today announced a strategic leadership transition designed to propel the company's next phase of AI-powered innovation and global growth. Effective October 6, Lisa Downey has been appointed Chief Executive Officer (CEO), while Mike Wilson, DrugBank's Co-Founder, will transition from CEO to Chief Product Officer (CPO), focusing on advancing DrugBank's AI and data intelligence capabilities.","length":509,"tagName":"p"},{"type":"image","alt":"Lisa Downey joins DrugBank as Chief Executive Officer (CEO) with nearly 20 years of experience in healthcare, life sciences, and data-driven transformation. (CNW Group/DrugBank)","displaySize":"","headline":null,"caption":"Lisa Downey joins DrugBank as Chief Executive Officer (CEO) with nearly 20 years of experience in healthcare, life sciences, and data-driven transformation. (CNW Group/DrugBank)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/f19ff10ff4e2bae82d8bfacda1772b18"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hXN8T03Bwd0u7YM.IGpUwg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/f19ff10ff4e2bae82d8bfacda1772b18","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2800812/DrugBank_DrugBank_Announces_Leadership_Transition_as_Company_Acc.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":" Leadership with Vision for the AI Era Lisa Downey brings nearly 20 years of experience in healthcare, life sciences, and data-driven transformation. Her leadership at Clarivate and GlobalData spanned data science, genomics, and real-world evidence, driving scale and innovation across complex, data-rich domains.","length":318,"tagName":"p"},{"type":"text","content":""DrugBank has an extraordinary foundation of data quality and scientific credibility," said Lisa Downey, CEO of DrugBank. "As we look ahead, we're building on that foundation to deliver a new generation of AI-driven insights that help our partners unlock faster, smarter drug discovery and development. The possibilities ahead are incredibly exciting."","length":376,"tagName":"p"},{"type":"text","content":" Founder Focuse...